×




Cipla Global Ltd.: Generics versus Drug Discovery Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Cipla Global Ltd.: Generics versus Drug Discovery case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Cipla Global Ltd.: Generics versus Drug Discovery case study is a Harvard Business School (HBR) case study written by V.S. Pai. The Cipla Global Ltd.: Generics versus Drug Discovery (referred as “Cgl Cipla” from here on) case study provides evaluation & decision scenario in field of Strategy & Execution. It also touches upon business topics such as - Value proposition, .

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Cipla Global Ltd.: Generics versus Drug Discovery Case Study


Cipla Global Ltd. (CGL) is a real-life, undisguised decision case. CGL is one of India's top pharmaceutical companies. Thanks to India's process patent regime (1970-2005), Dr. Yusuf Hamied, the company's chairman, managed to catapult the company to its position as a leading generics manufacturer. However, in 2005, India changed its Patents Act to make it TRIPS compliant. Faced with Western pharmaceutical companies' 'evergreening', CGL became a prominent crusader against multinationals. It fought and won patent cases in Indian courts. On the other hand, the government of India took advantage of the TRIPS provisions to authorize Indian companies to manufacture copies of patented drugs without the patent holder's permission. This infuriated Western pharmaceutical companies because they saw this provision as an infringement on their rights, which would lead to decreased revenues. As a consequence, they started lobbying their respective governments to put pressure on the Indian government. The case ends with a dilemma about the best course of action for CGL going forward, given the various options offered by the industry, on the one hand, and the ambitions of its chairman, on the other.


Case Authors : V.S. Pai

Topic : Strategy & Execution

Related Areas :




Calculating Net Present Value (NPV) at 6% for Cipla Global Ltd.: Generics versus Drug Discovery Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10004798) -10004798 - -
Year 1 3452895 -6551903 3452895 0.9434 3257448
Year 2 3960938 -2590965 7413833 0.89 3525221
Year 3 3943577 1352612 11357410 0.8396 3311103
Year 4 3248193 4600805 14605603 0.7921 2572873
TOTAL 14605603 12666645




The Net Present Value at 6% discount rate is 2661847

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Payback Period
2. Profitability Index
3. Net Present Value
4. Internal Rate of Return

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Cgl Cipla have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Cgl Cipla shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Cipla Global Ltd.: Generics versus Drug Discovery

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Strategy & Execution Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Cgl Cipla often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Cgl Cipla needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10004798) -10004798 - -
Year 1 3452895 -6551903 3452895 0.8696 3002517
Year 2 3960938 -2590965 7413833 0.7561 2995038
Year 3 3943577 1352612 11357410 0.6575 2592966
Year 4 3248193 4600805 14605603 0.5718 1857165
TOTAL 10447686


The Net NPV after 4 years is 442888

(10447686 - 10004798 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10004798) -10004798 - -
Year 1 3452895 -6551903 3452895 0.8333 2877413
Year 2 3960938 -2590965 7413833 0.6944 2750651
Year 3 3943577 1352612 11357410 0.5787 2282163
Year 4 3248193 4600805 14605603 0.4823 1566451
TOTAL 9476678


The Net NPV after 4 years is -528120

At 20% discount rate the NPV is negative (9476678 - 10004798 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Cgl Cipla to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Cgl Cipla has a NPV value higher than Zero then finance managers at Cgl Cipla can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Cgl Cipla, then the stock price of the Cgl Cipla should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Cgl Cipla should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Understanding of risks involved in the project.

What can impact the cash flow of the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Cipla Global Ltd.: Generics versus Drug Discovery

References & Further Readings

V.S. Pai (2018), "Cipla Global Ltd.: Generics versus Drug Discovery Harvard Business Review Case Study. Published by HBR Publications.


MaxCyte SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Yn Germanium A SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Jiangmen Sugar A SWOT Analysis / TOWS Matrix

Basic Materials , Paper & Paper Products


Kyocera Corp. SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls


Diverse Income Trust SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


Xenia Venture SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


Bitcoin Investment SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


Australian Vintage SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Beverages (Alcoholic)


Guy Degrenne SWOT Analysis / TOWS Matrix

Consumer Cyclical , Jewelry & Silverware